Detalhe da pesquisa
1.
A Combination of Chemotherapy and Oncolytic Virotherapy Sensitizes Colorectal Adenocarcinoma to Immune Checkpoint Inhibitors in a cDC1-Dependent Manner.
Int J Mol Sci
; 23(3)2022 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35163675
2.
Mechanisms of PD-L1 Regulation in Malignant and Virus-Infected Cells.
Int J Mol Sci
; 22(9)2021 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34063096
3.
Combined Radionuclide Therapy and Immunotherapy for Treatment of Triple Negative Breast Cancer.
Int J Mol Sci
; 22(9)2021 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34063642
4.
Multi-modal Potentiation of Oncolytic Virotherapy by Vanadium Compounds.
Mol Ther
; 26(1): 56-69, 2018 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29175158
5.
Oncolytic BHV-1 Is Sufficient to Induce Immunogenic Cell Death and Synergizes with Low-Dose Chemotherapy to Dampen Immunosuppressive T Regulatory Cells.
Cancers (Basel)
; 15(4)2023 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36831636
6.
IFNAR blockade synergizes with oncolytic VSV to prevent virus-mediated PD-L1 expression and promote antitumor T cell activity.
Mol Ther Oncolytics
; 25: 16-30, 2022 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35399605
7.
Tumor Heterogeneity: A Great Barrier in the Age of Cancer Immunotherapy.
Cancers (Basel)
; 13(4)2021 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33671881
8.
Response to FEC Chemotherapy and Oncolytic HSV-1 Is Associated with Macrophage Polarization and Increased Expression of S100A8/A9 in Triple Negative Breast Cancer.
Cancers (Basel)
; 13(21)2021 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34771752
9.
Immune checkpoint blockade in triple negative breast cancer influenced by B cells through myeloid-derived suppressor cells.
Commun Biol
; 4(1): 859, 2021 07 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34253827
10.
Experimental and natural evidence of SARS-CoV-2-infection-induced activation of type I interferon responses.
iScience
; 24(5): 102477, 2021 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33937724
11.
Hypoxia-Driven Immune Escape in the Tumor Microenvironment.
Cells
; 9(4)2020 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32316260
12.
Genetic modification of oncolytic viruses to enhance antitumor immunity.
Methods Enzymol
; 635: 231-250, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32122548
13.
De novo necroptosis creates an inflammatory environment mediating tumor susceptibility to immune checkpoint inhibitors.
Commun Biol
; 3(1): 645, 2020 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33149194
14.
Assessing the Completeness of Reporting in Preclinical Oncolytic Virus Therapy Studies.
Mol Ther Oncolytics
; 14: 179-187, 2019 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31276026
15.
Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy.
Sci Transl Med
; 10(422)2018 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29298865
16.
First-in-class small molecule potentiators of cancer virotherapy.
Sci Rep
; 6: 26786, 2016 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-27226390